110 related articles for article (PubMed ID: 38854732)
1. Stereotactic central/core ablative radiation therapy: results of a phase I study of a novel strategy to treat bulky tumor.
Yang J; Lu Q; Qi W; Kolb RD; Wang L; Li Y; Li S; Lin Y; Liu J; Mourad W; MirkhaghaniHaghighi F; Slavisa T; Wu X; You WC; Yang E; Hanlon A; Zhu A; Yan W
Front Oncol; 2024; 14():1364627. PubMed ID: 38854732
[TBL] [Abstract][Full Text] [Related]
2. Spatially Fractionated Radiation Therapy Using Lattice Radiation in Far-advanced Bulky Cervical Cancer: A Clinical and Molecular Imaging and Outcome Study.
Amendola BE; Perez NC; Mayr NA; Wu X; Amendola M
Radiat Res; 2020 Dec; 194(6):724-736. PubMed ID: 32853384
[TBL] [Abstract][Full Text] [Related]
3. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
Deodato F; Ferro M; Bonome P; Pezzulla D; Romano C; Buwenge M; Cilla S; Morganti AG; Macchia G
Strahlenther Onkol; 2024 Mar; 200(3):239-249. PubMed ID: 38180492
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of Proton stereotactic body radiation therapy for liver metastases.
Kang JI; Sufficool DC; Hsueh CT; Wroe AJ; Patyal B; Reeves ME; Slater JD; Yang GY
J Gastrointest Oncol; 2019 Feb; 10(1):112-117. PubMed ID: 30788166
[TBL] [Abstract][Full Text] [Related]
6. SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer.
Holyoake DLP; Robinson M; Silva M; Grose D; McIntosh D; Sebag-Montefiore D; Radhakrishna G; Mukherjee S; Hawkins MA
Radiother Oncol; 2021 Feb; 155():278-284. PubMed ID: 33217498
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors.
Hayashi K; Suzuki O; Shiomi H; Ono H; Setoguchi A; Nakai M; Nakanishi E; Tatekawa S; Ose N; Hirata T; Tamari K; Seo Y; Funaki S; Isohashi F; Shimizu S; Shintani Y; Ogawa K
BMC Cancer; 2023 Mar; 23(1):215. PubMed ID: 36882702
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.
Deodato F; Macchia G; Cilla S; Ianiro A; Sallustio G; Cammelli S; Buwenge M; Mattiucci GC; Valentini V; Morganti AG
Br J Radiol; 2019 Feb; 92(1094):20180422. PubMed ID: 30325662
[TBL] [Abstract][Full Text] [Related]
9. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
10. A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses.
Liauw SL; Ni L; Wu T; Arif F; Cloutier D; Posner MC; Kozloff M; Kindler HL
J Gastrointest Oncol; 2020 Dec; 11(6):1399-1407. PubMed ID: 33457009
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
Schefter TE; Kavanagh BD; Timmerman RD; Cardenes HR; Baron A; Gaspar LE
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1371-8. PubMed ID: 16029795
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
14. In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel Spacer.
Sawayanagi S; Yamashita H; Ogita M; Kawai T; Sato Y; Kume H
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672553
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Bezjak A; Paulus R; Gaspar LE; Timmerman RD; Straube WL; Ryan WF; Garces YI; Pu AT; Singh AK; Videtic GM; McGarry RC; Iyengar P; Pantarotto JR; Urbanic JJ; Sun AY; Daly ME; Grills IS; Sperduto P; Normolle DP; Bradley JD; Choy H
J Clin Oncol; 2019 May; 37(15):1316-1325. PubMed ID: 30943123
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of dose-escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results.
Qing S; Gu L; Zhang H
Cancer Med; 2021 Oct; 10(19):6736-6743. PubMed ID: 34405577
[TBL] [Abstract][Full Text] [Related]
19. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Tubin S; Popper HH; Brcic L
Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
